Production of RBC autoantibody mimicking anti-D specificity following transfusion in a patient with weak D Type 15.


Journal

Transfusion
ISSN: 1537-2995
Titre abrégé: Transfusion
Pays: United States
ID NLM: 0417360

Informations de publication

Date de publication:
04 2019
Historique:
received: 03 06 2018
revised: 19 11 2018
accepted: 03 12 2018
pubmed: 21 2 2019
medline: 20 5 2020
entrez: 21 2 2019
Statut: ppublish

Résumé

Weak D-type RBCs have fewer D epitopes, but it remains unclear whether individuals with certain types of weak D produce alloanti-D directed at D epitopes absent from the RBCs, and whether it is an alloantibody or an autoantibody. We report the first case of a patient with a weak D Type 15 who produced autoantibodies mimicking alloanti-D. A 52-year-old Japanese male with weak D developed anti-D 3 months after transfusion of D-negative and -positive RBCs, and the antibody persisted for 24 months with a consistently negative direct antiglobulin test. Eluates from the patient's RBCs demonstrated anti-D specificity. The recipient did not exhibit any signs of delayed hemolytic transfusion reaction. As his anti-D was removed by the different adsorbing cells of weak D Type 15 and autologous as well as D positive, D negative, weak D Type 24, and partial DVa, it was thought to be an autoantibody mimicking anti-D rather than an alloantibody. The patient's RBCs reacted weakly with the 13 anti-D reagents used in the study. Polymerase chain reaction and nucleotide sequencing revealed that the patient had an RHD genotype of RHD*01N.01/RHD*15. Anti-D, produced in a patient with weak D Type 15 after transfusion, was found to be mimicking autoanti-D. Alloanti-D was excluded by an adsorption study with different RBC types.

Sections du résumé

BACKGROUND
Weak D-type RBCs have fewer D epitopes, but it remains unclear whether individuals with certain types of weak D produce alloanti-D directed at D epitopes absent from the RBCs, and whether it is an alloantibody or an autoantibody. We report the first case of a patient with a weak D Type 15 who produced autoantibodies mimicking alloanti-D.
CASE REPORT
A 52-year-old Japanese male with weak D developed anti-D 3 months after transfusion of D-negative and -positive RBCs, and the antibody persisted for 24 months with a consistently negative direct antiglobulin test. Eluates from the patient's RBCs demonstrated anti-D specificity. The recipient did not exhibit any signs of delayed hemolytic transfusion reaction. As his anti-D was removed by the different adsorbing cells of weak D Type 15 and autologous as well as D positive, D negative, weak D Type 24, and partial DVa, it was thought to be an autoantibody mimicking anti-D rather than an alloantibody. The patient's RBCs reacted weakly with the 13 anti-D reagents used in the study. Polymerase chain reaction and nucleotide sequencing revealed that the patient had an RHD genotype of RHD*01N.01/RHD*15.
CONCLUSION
Anti-D, produced in a patient with weak D Type 15 after transfusion, was found to be mimicking autoanti-D. Alloanti-D was excluded by an adsorption study with different RBC types.

Identifiants

pubmed: 30784074
doi: 10.1111/trf.15207
doi:

Substances chimiques

Isoantibodies 0
RHO(D) antibody 0
Rho(D) Immune Globulin 0

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

1190-1195

Informations de copyright

© 2019 AABB.

Auteurs

Chikako Takeuchi-Baba (C)

Department of Clinical Laboratory, Tomishiro Central Hospital, Okinawa, Japan.

Shoichi Ito (S)

Japanese Red Cross Tohoku Block Center, Sendai, Japan.

Rie Kinjo (R)

Department of Clinical Laboratory, Tomishiro Central Hospital, Okinawa, Japan.

Hitomi Miyagi (H)

Department of Clinical Laboratory, Tomishiro Central Hospital, Okinawa, Japan.

Hiroyasu Yasuda (H)

Division of Medical Technology, Fukushima Prefectural Hygiene Institute, Fukushima, Japan.

Kenichi Ogasawara (K)

Japanese Red Cross Central Blood Institute, Tokyo, Japan.

Hitoshi Ohto (H)

Department of Advanced Cancer Immunotherapy, Fukushima Medical University, Fukushima, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH